What’s new in IMHA?

Immune‐mediated haemolytic anaemia (IMHA) is an important cause of morbidity and mortality in dogs. IMHA also occurs in cats, although less commonly. IMHA is considered secondary when it can be attributed to an underlying disease, and as primary (idiopathic) if no cause is found. Eliminating diseases that cause IMHA may attenuate or stop immune‐mediated erythrocyte destruction, and adverse consequences of long‐term immunosuppressive treatment can be avoided. Infections, cancer, drugs, vaccines, and inflammatory processes may be underlying causes of IMHA. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarians as to the optimal regimen to employ and maintain after diagnosis of the disease. In this webinar, Scott will discuss the most effective ways to diagnose IMHA and consolidate your knowledge of the pathophysiology of the disease. We will also review the most recent treatment options, especially when the steroids don’t work.

Scott Kilpatrick

Director, Internal Medicine Specialist

show

Scott graduated from Edinburgh Vet School in 2007. Initially, he worked for the PDSA, before taking a Senior Veterinary Surgeon position with Vets Now in Edinburgh in 2010. Scott started his residency in internal medicine at the University of Edinburgh in 2012 after completing a year as a Teaching Fellow in Anatomy and Physiology. He completed his residency in 2016 after finishing his Masters in the pathogenesis of canine liver disease and has since been working in referral practice. Interventional radiology is something that really interests Scott, and he spent some time in 2018, working in this area at UC Davis in California. Scott has created and delivered a Post-graduate Certificate in Small Animal Emergency Medicine in association with the University of Chester. In 2023 he was awarded Fellow of the Royal College of Veterinary Surgeons (FRCVS) for his meritorious contribution to clinical practice.